NCB Busts Major Drug Racket In Mumbai, Pune; Arrests Seven

Mumbai : The Narcotics Control Bureau (NCB) arrested seven persons from Mumbai and Pune and allegedly seized 2.112 kilograms (kg) of Mephedrone, 3.9kgs of Ephedrine, and 45 grams of Charas.

Based on the specific information, the Mumbai NCB team raided a house at Kausa in Mumbra and found 1.75kgs of Mephedrone and 3.9kgs of Ephedrine. We nabbed Sahil Hamid Mulla Aji, who is the owner of the house, and his associate Ibrahim Ismail Jhangir. The third accused, Irfan Parmar, was also nabbed from the same house. Parmar, who hails from Gujarat, bought 300 grams of Mephedrone from Aji. The contraband was also recovered from his possession, said NCB zonal director Sameer Wankhede.

“After interrogating Aji and Jhangir, we got a lead about the main conspirator of the case and a team immediately went to Pune and arrested one Nadeem Shaikh from Kharadi. During search, NCB found 45 grams of charas from his possession,” added Wankhede. The four accused were arrested under Narcotic Drugs and Psychotropic Substances (NDPS) Act and further investigation is going on.

In the second operation, NCB arrested Rehan Shaikh from Goregon area and allegedly seized 62 grams of Mephedrone. During interrogation, the agency learnt that he was a consumer and a drug peddler from the past four to five years. NCB Mumbai registered a separate case against him under NDPS Act.

While looking for more accused in a previous case, NCB arrested Jay Prakash Bhat alias Jitu from Andheri and Vijay Kumar Singh alias Rehan Chicken alias Monty from Bandra. Both were wanted in a previous drug case registered in July in which they have arrested three accused including a woman.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’